Strategic Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,436
Closed -$238K 187
2025
Q1
$238K Sell
1,436
-236
-14% -$36.9K 0.05% 169
2024
Q4
$242K Sell
1,672
-1,906
-53% -$295K 0.04% 177
2024
Q3
$580K Sell
3,578
-12
-0.3% -$1.91K 0.11% 133
2024
Q2
$525K Sell
3,590
-72
-2% -$10.7K 0.1% 135
2024
Q1
$579K Sell
3,662
-1,870
-34% -$298K 0.11% 131
2023
Q4
$867K Sell
5,532
-224
-4% -$34.3K 0.16% 113
2023
Q3
$897K Sell
5,756
-79,937
-93% -$13.2M 0.18% 106
2023
Q2
$14.2M Sell
85,693
-1,178
-1% -$190K 2.7% 8
2023
Q1
$13.5M Buy
86,871
+5,400
+7% +$872K 2.73% 6
2022
Q4
$14.4M Buy
81,471
+161
+0.2% +$27.8K 3.21% 4
2022
Q3
$13.3M Buy
81,310
+656
+0.8% +$111K 2.95% 6
2022
Q2
$14.3M Buy
80,654
+28
+0% +$4.99K 2.99% 6
2022
Q1
$14.3M Buy
80,626
+990
+1% +$168K 2.48% 8
2021
Q4
$13.6M Buy
79,636
+38,892
+95% +$6.37M 1.94% 12
2021
Q3
$6.58M Buy
40,744
+20,563
+102% +$3.51M 1.42% 16
2021
Q2
$3.32M Sell
20,181
-19,415
-49% -$3.21M 0.86% 24
2021
Q1
$6.51M Buy
39,596
+2,346
+6% +$380K 1.89% 13
2020
Q4
$5.97M Buy
37,250
+15,045
+68% +$2.22M 1.73% 14
2020
Q3
$3.29M Sell
22,205
-1,034
-4% -$153K 1.1% 21
2020
Q2
$3.49M Buy
23,239
+373
+2% +$54.4K 1.3% 18
2020
Q1
$3.28M Buy
22,866
+843
+4% +$120K 1.43% 17
2019
Q4
$3.21M Sell
22,023
-1,889
-8% -$256K 1.12% 19
2019
Q3
$3.09M Sell
23,912
-6,712
-22% -$884K 1.16% 18
2019
Q2
$4.26M Sell
30,624
-22,377
-42% -$3.1M 1.63% 16
2019
Q1
$7.41M Sell
53,001
-717
-1% -$96K 2.86% 5
2018
Q4
$6.93M Sell
53,718
-3,062
-5% -$427K 3.03% 5
2018
Q3
$7.84M Sell
56,780
-812
-1% -$108K 2.87% 5
2018
Q2
$6.99M Buy
57,592
+187
+0.3% +$23.3K 2.81% 6
2018
Q1
$7.36M Buy
57,405
+2,422
+4% +$327K 3.04% 4
2017
Q4
$7.68M Sell
54,983
-868
-2% -$121K 3.14% 4
2017
Q3
$7.26M Sell
55,851
-625
-1% -$82.9K 3.15% 4
2017
Q2
$7.47M Sell
56,476
-189
-0.3% -$24.1K 3.41% 3
2017
Q1
$7.06M Sell
56,665
-3,566
-6% -$426K 3.33% 3
2016
Q4
$6.94M Buy
60,231
+418
+0.7% +$48.3K 3.64% 5
2016
Q3
$7.07M Sell
59,813
-161
-0.3% -$19.5K 3.96% 2
2016
Q2
$7.28M Sell
59,974
-21
-0% -$2.39K 4.2% 2
2016
Q1
$6.49M Buy
59,995
+1,872
+3% +$194K 3.69% 4
2015
Q4
$5.97M Sell
58,123
-254
-0.4% -$25.5K 3.91% 2
2015
Q3
$5.45M Buy
58,377
+7,660
+15% +$741K 3.78% 2
2015
Q2
$4.94M Buy
50,717
+2,761
+6% +$276K 3.15% 5
2015
Q1
$5.02M Buy
47,956
+152
+0.3% +$15.5K 3.22% 3
2014
Q4
$5M Buy
47,804
+1,355
+3% +$143K 3.26% 3
2014
Q3
$4.95M Sell
46,449
-1,507
-3% -$156K 3.25% 3
2014
Q2
$5.02M Buy
47,956
+1,224
+3% +$124K 3.21% 3
2014
Q1
$4.59M Buy
46,732
+1,383
+3% +$128K 3.08% 3
2013
Q4
$4.15M Buy
45,349
+1,837
+4% +$169K 2.83% 3
2013
Q3
$3.77M Buy
43,512
+4,263
+11% +$382K 3.1% 2
2013
Q2
$3.4M Buy
+39,249
New +$3.33M 3.04% 3

Other funds holding JNJ

Strategic Advisors's JNJ Position: Q2 2025 in Review

Strategic Advisors sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 1,436 shares — an estimated $238K sold.

Strategic Advisors first reported a position in JNJ in Q2 2013 and held it in 48 quarters. The position peaked at $14.4M in Q4 2022. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Strategic Advisors reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Strategic Advisors sold 1,436 Johnson & Johnson shares in Q2 2025, an estimated $238K.
  • Strategic Advisors first reported a position in Johnson & Johnson in Q2 2013 and held it in 48 quarters.
  • Strategic Advisors's Johnson & Johnson position peaked at $14.4M in Q4 2022.
  • 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Strategic Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.